The latest quarterly EBT is $385.94 Million with a QoQ Growth of +23.34%. Earnings Before Tax (EBT), also called pre-tax income, represents a company's profit after all operating and non-operating expenses but before income tax expense.
Q2 FY2026 (2026-06-30).
Reported quarterly EBT; no daily interpolation. Q2 FY2026 (2026-06-30): $385.94M.
$385.94M
$385.94 Million
Q2 FY2026 · 2026-06-30
+23.34%
vs. $312.92M prior quarter
55
Quarters of data available
| Period | EBT | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $385.94M | +23.34% | +34.50% |
| Q1 FY2026Period end 2026-03-27 | $312.92M | +51.43% | +121.87% |
| Q4 FY2025Period end 2025-12-31 | $206.65M | -68.32% | -48.32% |
| Q3 FY2025Period end 2025-09-30 | $652.27M | +127.32% | +99.41% |
| Q2 FY2025Period end 2025-06-30 | $286.94M | +103.45% | -9.58% |
| Q1 FY2025Period end 2025-03-31 | $141.04M | -64.73% | -38.96% |
| Q4 FY2024Period end 2024-12-31 | $399.87M | +22.25% | -17.23% |
| Q3 FY2024Period end 2024-09-30 | $327.11M | +3.08% | +44.18% |
| Q2 FY2024Period end 2024-06-30 | $317.32M | +37.34% | -16.92% |
| Q1 FY2024Period end 2024-03-31 | $231.05M | -52.17% | -4.18% |
| Q4 FY2023Period end 2023-12-31 | $483.10M | +112.94% | +40.92% |
| Q3 FY2023Period end 2023-09-30 | $226.87M | -40.60% | N/A |
| Q2 FY2023Period end 2023-06-30 | $381.97M | +58.41% | +469.54% |
| Q1 FY2023Period end 2023-03-31 | $241.12M | -29.66% | +49.48% |
| Q4 FY2022Period end 2022-12-31 | $342.81M | N/A | +10.99% |
| Q3 FY2022Period end 2022-09-30 | −$60.38M | N/A | N/A |
| Q2 FY2022Period end 2022-06-30 | $67.07M | -58.42% | -79.03% |
| Q1 FY2022Period end 2022-03-31 | $161.31M | -47.77% | -15.13% |
| Q4 FY2021Period end 2021-12-31 | $308.86M | +25.05% | +12.25% |
| Q3 FY2021Period end 2021-09-30 | $246.99M | -22.76% | +54.71% |
| Q2 FY2021Period end 2021-06-30 | $319.78M | +68.25% | +32.63% |
| Q1 FY2021Period end 2021-03-31 | $190.06M | -30.92% | N/A |
| Q4 FY2020Period end 2020-12-31 | $275.15M | +72.36% | +171.73% |
| Q3 FY2020Period end 2020-09-30 | $159.64M | -33.79% | +54.13% |
| Q2 FY2020Period end 2020-06-30 | $241.10M | N/A | +185.72% |
| Q1 FY2020Period end 2020-03-31 | −$296.41M | N/A | N/A |
| Q4 FY2019Period end 2019-12-31 | $101.26M | -2.24% | +436.34% |
| Q3 FY2019Period end 2019-09-30 | $103.58M | +22.75% | +97.88% |
| Q2 FY2019Period end 2019-06-30 | $84.38M | -37.94% | +65.22% |
| Q1 FY2019Period end 2019-03-31 | $135.96M | +620.13% | +119.13% |
| Q4 FY2018Period end 2018-12-31 | $18.88M | -63.93% | -86.21% |
| Q3 FY2018Period end 2018-09-30 | $52.34M | +2.49% | -40.80% |
| Q2 FY2018Period end 2018-06-30 | $51.07M | -17.69% | -55.62% |
| Q1 FY2018Period end 2018-03-31 | $62.05M | -54.69% | N/A |
| Q4 FY2017Period end 2017-12-31 | $136.94M | +54.87% | +39.08% |
| Q3 FY2017Period end 2017-09-30 | $88.42M | -23.16% | -29.50% |
| Q2 FY2017Period end 2017-06-30 | $115.08M | N/A | +38.64% |
| Q1 FY2017Period end 2017-03-31 | −$190.59M | N/A | N/A |
| Q4 FY2016Period end 2016-12-31 | $98.46M | -21.50% | N/A |
| Q3 FY2016Period end 2016-09-30 | $125.42M | +51.10% | N/A |
| Q2 FY2016Period end 2016-06-30 | $83.01M | N/A | +44.23% |
| Q1 FY2016Period end 2016-03-31 | −$8.97M | N/A | N/A |
| Q4 FY2015Period end 2015-12-31 | $9.57M | N/A | -94.29% |
| Q3 FY2015Period end 2015-09-30 | −$32.09M | N/A | +58.27% |
| Q2 FY2015Period end 2015-06-30 | $57.55M | +23.90% | -69.95% |
| Q1 FY2015Period end 2015-03-31 | $46.45M | -72.29% | -83.09% |
| Q4 FY2014Period end 2014-12-31 | $167.64M | N/A | -51.34% |
| Q3 FY2014Period end 2014-09-30 | −$76.89M | N/A | N/A |
| Q2 FY2014Period end 2014-06-30 | $191.49M | -30.29% | N/A |
| Q1 FY2014Period end 2014-03-31 | $274.68M | -20.27% | +10.94% |
| Q4 FY2013Period end 2013-12-31 | $344.49M | -16.18% | +207.47% |
| Q3 FY2013Period end 2013-09-30 | $410.99M | N/A | N/A |
| Q2 FY2013Period end 2013-06-30 | −$130.42M | N/A | N/A |
| Q1 FY2013Period end 2013-03-31 | $247.58M | +120.98% | N/A |
| Q4 FY2012Period end 2012-12-31 | $112.04M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
